Genome Medical and Pierian Announce Collaboration
Partnership Combines Services and Tools to Help Providers and Health Organizations Build and Expand Internal Testing Capabilities Genome Medical, the leading telehealth provider of genetic...
Tag : full genome sequencing
Illumina Genomics Forum to Feature Nobel Laureate Frances Arnold
Speakers will discuss how genomics drives more informed, inclusive, and proactive care Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today...
Beam Therapeutics announces new preclinical data
Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced new preclinical data demonstrating the potential of the company’s...
Fabric Genomics Expands Leadership Team in Precision Medicine
Former Chief Scientific Officer of GeneDx Sean Hofherr Joins as Chief Operating Officer and Clinical Director Fabric Genomics, Inc., a leader in AI-driven precision medicine,...
GenScript Receives Best Cell & Gene Therapy Supplier Award
GenScript Biotech Corporation (“GenScript”, Stock Code: 1548.HK) and GenScriptProBio (a global one-stop CDMO from GenScript Group) receive 3 awards: Best Cell & Gene Therapy Supplier...
SparingVision Raises €75 Million Series B
SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases Proceeds to fund first-in-human trials of breakthrough gene therapy products, SPVN06 and SPVN20, and advance CRISPR-based genome editing portfolio...
Debiopharm Co-leads a 10M USD Series A Round
Debiopharm Innovation Fund strategically invests in Whitelab Genomics’ mission to make genomic medicine development faster and leaner for more efficient access to cancer patients in...
EDGC recruits Sam Martin, VP of Overseas Business Development
An expert from Invitae and Ambry Genetics, U.S. genome analysis companies EDGC states, “We will expand the overseas genome analysis market and advance into the...
Reveal Genomics®️ Presents New Validation Data of Her2dx
Presented during the ESMO Congress 2022, HER2DX®️ predicts the response of trastuzumab, pertuzumab and letrozole in patients with HER2+ HR+ breast cancer. This is the first...
S2 Genomics Announces Distribution Agreement with Techtum Lab AB
Singulator™ 100 System and components to be available through local distributor in Norway, Finland, Denmark and Sweden. S2 Genomics, Inc. today announced that it has...